Real‐World Molecular Testing in European Early‐Onset Colorectal Cancer
United European Gastroenterology Journal · 2025
DOI: 10.1002/ueg2.70112 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Penelope V Edwards und 33 weiteren Autor:innen. Beteiligte Einrichtung: The Centre for Familial Intestinal Cancer, St Mark's Hospital, London Northwest Healthcare Trust, London, UK. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Genetic Testing, Biomarkers, Tumor. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, 40tude Curing Colon Cancer Charity.
Abstract (Originalsprache)
Purpose
The global incidence and mortality of early‐age onset colorectal cancer (EOCRC, or CRC diagnosed under 50 years) has increased in recent decades. High‐risk surveillance and personalised oncological treatment may improve patients' outcomes. This study aims to characterise real‐world somatic and germline molecular profiles in European EOCRC patients. Patients and Methods Consecutive patients across the UK, Spain, Germany and Italy from the GEOCODE and SECOC consortia were identified using electronic patient records. Clinicopathological, somatic and germline testing data were collected on EOCRC patients. Tests included mismatch repair (MMR), somatic next generation sequencing (NGS) and germline multi‐gene panels.
Results
Eight hundred ninety‐three EOCRC patients were identified from 23 European centres (45.7% female, median age 42, range 14–49), predominantly in the distal colorectum: 205/893 (22.9%) patients with right‐sided tumours, 302/893 (33.8%) left‐sided tumours, 288/893 (32.2%) rectal tumours and 97/893 (10.8%) unknown. On somatic analysis, 735/893 (82.3%) of patients had pMMR tumours and 148/893 (16.5%) dMMR. Although 534/893 (59.7%) did not receive NGS somatic testing, somatic variants were detected in 233/359 (64.9%) of those tested. Germline variants were detected in 133/210 (63.3%) patients tested. Lynch syndrome was diagnosed in 93/210 (44.2%), of whom 17/93 (18.2%) presented with pMMR tumours. Systematic recording of family history in these real‐world data was variable. In all patients with family history recorded, 153/484 (31.4%) patients reported a relative with CRC.
Conclusions
Our results support universal and paired somatic and germline multi‐gene panels for all EOCRC patients, regardless of MMR status or family history. Systematic molecular testing approaches are necessary to address disparities in people with EOCRC. Larger unselected cohort studies would support validation of testing prediction models and estimates of clinically relevant variant actionability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Centre for Familial Intestinal Cancer, St Mark's Hospital, London Northwest Healthcare Trust, London, UK.
- Cancer Genetics, Royal Marsden NHS Trust, London, UK.
- Department of Surgery and Cancer, Imperial College London, London, UK.
- Chelsea and Westminster NHS Trust, London, UK.
- National Center for Hereditary Tumour Syndromes, University Hospital Bonn, Bonn, Germany.
- Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
ORCID-Profile: Penelope V Edwards, Huw Thomas, Filomena Liccardo, Robert Hüneburg, Francesc Balaguer, Lorena Brandáriz, Rosario Vidal-Tocino, Carlos Pastor, Rogelio González-Sarmiento, Terri McVeigh, José Perea, Kevin J Monahan
Förderung
- Instituto de Salud Carlos III
- 40tude Curing Colon Cancer Charity
Zitieren
APA
Edwards, P. V., Ali Eloussta, K. G., Latchford, A., Faiz, O., Thomas, H., Liccardo, F., Pawa, N., Hüneburg, R., Nattermann, J., George, A., Balaguer, F., Martí, M., Spinelli, A., Foppa, C., de Miranda, N. F. F. C., López, I., Hurtado, E., Jiménez, F., Jiménez-Toscano, M., …, & Collaborators GEOCODE and SECOC Consortia (2025). Real‐World Molecular Testing in European Early‐Onset Colorectal Cancer. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70112
Vancouver
Edwards PV, Ali Eloussta KG, Latchford A, Faiz O, Thomas H, Liccardo F, et al. Real‐World Molecular Testing in European Early‐Onset Colorectal Cancer. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70112
BibTeX
@article{Edwards2025,
author = {Edwards, Penelope V and Ali Eloussta, Kussai Giuma and Latchford, Andrew and Faiz, Omar and Thomas, Huw and Liccardo, Filomena and Pawa, Nikhil and Hüneburg, Robert and Nattermann, Jacob and George, Andrew and Balaguer, Francesc and Martí, Marc and Spinelli, Antonino and Foppa, Caterina and de Miranda, Noel F F C and López, Irene and Hurtado, Elena and Jiménez, Fernando and Jiménez-Toscano, Marta and Álvaro, Edurne and Sanz, Gonzalo and Ballestero, Araceli and Rueda, José A and Viyuela, Cristina and Brandáriz, Lorena and Vidal-Tocino, Rosario and García-Olmo, Damián and Pastor, Carlos and González-Sarmiento, Rogelio and Holowatyj, Andreana N and McVeigh, Terri and Perea, José and Monahan, Kevin J and Collaborators GEOCODE and SECOC Consortia, Collaborators GEOCODE and SECOC Consortia},
title = {Real‐World Molecular Testing in European Early‐Onset Colorectal Cancer},
journal = {United European Gastroenterology Journal},
year = {2025},
doi = {10.1002/ueg2.70112}
}
EUVIMED